Register now to the CPhI webinar on excipients
webinar – 31/08/2022
The CPhI is organising a – free – webinar on Why the Excipients Market Needs to Embrace the New Normal.
When? On 31 August at 4pm CET/10am EST.
More info and registrations here
Register now to the CPhI webinar
webinar – 26/01/2022
Our EFCG Vice-President Gildas Barreyre (General Secretary, SEQENS) and Dirkjan van Zoelen (Manager Development and Technical Support, Aspen Oss B.V), EFCG members, will share their experience and insights on the pharmaceutical supply chain integrity and resilience at the CPhI webinar on 26th January.
Health industries propose concrete measures to secure the supply chain of medicines
SICOS Press Release – 27/10/2021
For a proactive industrial policy for the pharmaceutical industry to guarantee sustainable safety and health autonomy: on the basis of a study carried out by PwC Strategy&, the health industries propose concrete measures adapted to the different types of vulnerabilities identified.
Joint statement by EFCG and BPTF on addressing the challenges of the pharmaceutical supply chain
The COVID 19 crisis has further exacerbated the structural problem which has been building up throughout the recent decade. The fact that many APIs can only be sourced outside the U.S. and Europe and that the production of some drugs (e.g., injectables) was exited years ago due to low sustainability of margins, left both continents with limited supplies of some specific but vital drugs.
Excipients – An industry adapting to change
Innovative medicines need innovative excipients
Position paper – 15/03/2021
Novel excipients are essential for the development of new medicines and vaccines. They foster patient access to innovative and affordable medicines.
Their use can also help to formulate drugs improving their efficacy, quality and safety.
Read our position paper